Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

GSK 2334470, Tocris Bioscience™

Catalog No. p-4816516 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Highly potent, selective PDPK1 (PDK1) inhibitor

Potent 3-phosphoinositide-dependent protein kinase (PDPK1) inhibitor (IC50 ∽ 10 nM). Exhibits no effect on other kinases including Aurora, ROCK, p38 MAPK and PI 3-K. Suppresses T-loop phosphorylation and subsequent activation of PDK1 substrates S6K1, SGK and RSK in vitro; exhibits limited inhibitory effect on Akt activation. Delays melanomagenesis and metastasis in BrafV600E::Pten(-/-) mice.

Chemical Identifiers

CAS 1227911-45-6
Molecular Formula C25H34N8O
Molecular Weight (g/mol) 462.602
InChI Key QLPHOXTXAKOFMU-WBVHZDCISA-N
Synonym 3s,6r-1-6-3-amino-1h-indazol-6-yl-2-methylamino-4-pyrimidinyl-n-cyclohexyl-6-methyl-3-piperidinecarboxamide, 3s,6r-1-6-3-amino-1h-indazol-6-yl-2-methylamino pyrimidin-4-yl-n-cyclohexyl-6-methylpiperidine-3-carboxamide, d0eu1r, pdk1 inhibitors, glaxosmithkline, gsk hplc, 3-piperidinecarboxamide, 1-6-3-amino-1h-indazol-6-yl-2-methylamino-4-pyrimidinyl-n-cyclohexyl-6-methyl-, 3s,6r
PubChem CID 46215815
IUPAC Name (3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl]-N-cyclohexyl-6-methylpiperidine-3-carboxamide
SMILES CC1CCC(CN1C2=NC(=NC(=C2)C3=CC4=C(C=C3)C(=NN4)N)NC)C(=O)NC5CCCCC5

Specifications

Quantity 10 mg
Formula Weight 462.59
Percent Purity >98%
Chemical Name or Material GSK 2334470
Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.